Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Introgen Therapeutics -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (587)	12/12/2006 3:05:05 PM
From: Jibacoa	Read Replies (1) \| Respond to of 802

Yes, they keep trying to keep the stock above the $4.50 level.<g> (But with another day like today they better come out with something else before the C.C. <g>) bigcharts.marketwatch.com <b<Introgen Announces Conference Call. Tuesday December 12, 2:50 pm ET AUSTIN, Texas, Dec. 12 /PRNewswire-FirstCall/ -- Introgen Therapeutics, Inc. (Nasdaq: INGN - News) announced today that it has scheduled a conference call to discuss its regulatory, clinical and corporate developments, and financial results for the quarter ended September 30, 2006. The call will be held on December 28, 2006, at 4:30 p.m. Eastern Time. The call may be accessed at Introgen's Web site at introgen.com . The call may also be accessed by dialing 1-877-616-4476 or 1-706-679-7372. For those unable to listen to the broadcast live, the call will be archived for replay on Introgen's website.